I-Mab Strengthens Management Team Designed to Accelerate Glo

- New appointments as part of the Company's strategic development plans to accelerate transformation towards commercialization - Dr. Andrew Zhu, an...

Related Keywords

Guangzhou , Guangdong , China , Shanghai , United States , Hong Kong , Xujiahui , Zhejiang , Massachusetts , Lishui , Beijing , Gaithersburg , Maryland , San Diego , California , Peking , Hangzhou , Emilie Wu , Andrew Zhu , Gigi Feng , Jingwu Zang , Eli Lilly , Weimin Tang , Jielun Zhu , Yifei Zhu , Wei Fu , Joan Shen , John Long , Company Nasdaq , Twitter , Commercialization Executive Council , Nasdaq , Yale School Of Medicine , Steering Committee , Corporate Governance Committee , Cancer Center , Professor Of Medicine At Harvard Medical School , Harvard Medical School , Piacente Group Inc , Liver Cancer Research At Massachusetts , Oncology At Memorial Sloan Kettering Cancer Center , Columbia University , Exchange Commission , Jiahui International Hospital , University Health Science Center , Acting Chief Executive , Scientific Advisory , Acting Chief Executive Officer , I Mab Biopharma , Chief Strategy Officer , Chief Commercial Officer , Chief Business Officer , Chief Financial Officer , Liver Cancer Research , Massachusetts General Hospital , Trial Design , Practice Guidelines , Hepatobiliary Cancers , Hepatocellular Carcinoma , Systemic Therapy , Advanced Hepatocellular , Peking University Health Science Center , Harvard Medical , Yale New Heaven Hospital , Yale School , Memorial Sloan Kettering Cancer , England Journal , Nature Medicine , Lancet Oncology , Clinical Oncology , Chief Financial , Chief Communications , Piacente Group , I Mab ,